1. Pink Sheet
  2. >>Compliance
  3. >>Distribution/Supply Chain

Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

 
• By Sue Sutter

Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.

Supply chain
Drug shortages, foreign manufacturing and supply chain vulnerability were a common, intertwined thread throughout the appropriations subcommittee hearing. • Source: Shutterstock

In between many tobacco and vaping questions, US Food and Drug Administration Commissioner Robert Califf still managed to tout priorities important to drug oversight during a House subcommittee hearing on the agency's fiscal year 2025 budget request.

The Biden Administration has requested $7.2bn for the FDA in FY 2025, including $3.5bn in user fees and $3.7bn in discretionary budget authority

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Distribution/Supply Chain

More from Compliance